Enanta Pharmaceuticals, Inc. (ENTA)
Enanta Pharmaceuticals Market Cap: 363.38M for Jan. 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Agios Pharmaceuticals, Inc. | 1.585B |
| NovaBay Pharmaceuticals, Inc. | 740.64M |
| Palatin Technologies, Inc. | 15.29M |
| Theriva Biologics, Inc. | 6.471M |
| Oragenics, Inc. | 0.8147M |
Market Cap Related Metrics
| PS Ratio | 4.112 |
| Price to Book Value | 5.615 |
| Price | 12.59 |
| Earnings Yield | -30.49% |